MediWound (MDWD) Retained Earnings (2013 - 2025)
MediWound's (MDWD) quarterly Retained Earnings came in at -$228.9 million in Q4 2025, down 11.63% year-on-year from -$259.0 million in Q4 2024, and down 4.48% quarter-over-quarter from -$219.1 million in Q2 2025.
MediWound (MDWD) Retained Earnings (2013 - 2025) Analysis & Trends
MediWound's Retained Earnings history runs 13 years deep, the most recent figure standing at -$228.9 million for Q4 2025.
- On a quarterly basis, Retained Earnings fell 11.63% year-over-year to -$228.9 million in Q4 2025; TTM through Dec 2025 was -$228.9 million, a 11.63% decrease from a year earlier, with the FY2025 full-year figure at -$228.9 million, down 11.63% from the prior year.
- Retained Earnings fell to -$228.9 million in Q4 2025 per MDWD's latest filing, from -$219.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$137.8 million in Q1 2021 and bottomed at -$228.9 million in Q4 2025.
- The 5-year median for Retained Earnings is -$164.4 million (2022), against an average of -$171.3 million.
- Across the five-year window, Retained Earnings slipped 4.0% in 2023 and declined 17.29% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$148.5 million in 2021, then decreased by 13.2% to -$168.1 million in 2022, then fell by 4.0% to -$174.8 million in 2023, then declined by 17.29% to -$205.0 million in 2024, then dropped by 11.63% to -$228.9 million in 2025.
- Per Business Quant, the three latest MDWD Retained Earnings figures stand at -$228.9 million (Q4 2025), -$219.1 million (Q2 2025), and -$205.0 million (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | -228.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -228.90 Mn |
| Jun 30, 2025 | -219.09 Mn |
| Dec 31, 2024 | -205.05 Mn |
| Jun 30, 2024 | -190.86 Mn |
| Dec 31, 2023 | -174.82 Mn |
| Jun 30, 2023 | -170.88 Mn |
| Dec 31, 2022 | -168.11 Mn |
| Sep 30, 2022 | -160.65 Mn |
| Jun 30, 2022 | -156.45 Mn |
| Mar 31, 2022 | -152.10 Mn |
| Dec 31, 2021 | -148.51 Mn |
| Sep 30, 2021 | -144.35 Mn |
| Jun 30, 2021 | -141.00 Mn |
| Mar 31, 2021 | -137.81 Mn |
| Dec 31, 2020 | -134.96 Mn |
| Sep 30, 2020 | -133.22 Mn |
| Jun 30, 2020 | -131.32 Mn |
| Mar 31, 2020 | -128.22 Mn |
| Dec 31, 2019 | -125.76 Mn |
| Sep 30, 2019 | -122.32 Mn |